Objectives: Both the hemostatic and inflammatory system are thought to play a role in the pathogenesis of acute coronary syndromes. However, their respective contribution and interrelationship remain unclear, therefore, we studied the relationship between activation of the coagulation system and proinflammatory activity in ischemic coronary syndromes. Methods: Thrombin-antithrombin III (TAT), prothrombin fragments F , fibrinopeptide A (FPA), interleukin-6 (IL-6) and interleukin-8 (IL-8) were measured in 50 patients with 112 unstable angina (UA), 60 patients with acute myocardial infarction (AMI) and in 50 patients with stable angina (SA). Results: FPA levels were significantly higher in patients with UA and AMI than in patients with SA ( p50.0015 and p,0.0001), and were higher in patients with AMI than UA ( p50.0013). Plasma IL-6 concentrations were significantly higher in patients with UA and AMI than in patients with SA ( p50.0020 and p,0.001), and again were higher in AMI than UA ( p50.001). Interestingly, FPA or IL-6 elevations on admission were found in different patients. In contrast, TAT, F and IL-8 levels were not different between the three groups. Conclusions: and FPA were shown to be independent predictive markers with equal discriminative power to distinguish stable (SA) from unstable (UA1AMI) patients. Moreover, hemostatic and inflammatory markers can be elevated independently in the acute phase of ischemic coronary syndromes.
Introduction
persistent hypercoagulable state has been demonstrated in patients with UA or AMI long after clinical stabilization Partial or complete thrombotic occlusion of a coronary [2] . artery, secondary to rupture of an atherosclerotic plaque, is
More recently, an inflammatory component has also the key event in the development of acute ischemic been suggested to play a role in the progression to acute coronary syndromes [1] . In various studies, evidence of coronary syndromes [7] [8] [9] [10] . Activated macrophages and activation of the hemostatic system has been demonstrated T-lymphocytes have been demonstrated at the site of in the acute phase of coronary artery disease [2] [3] [4] . Thus, plaque disruption [11] and, in a substantial proportion of elevated levels of thrombin-antithrombin III (TAT), propatients with unstable angina (UA), elevated plasma levels thrombin fragments F and fibrinopeptide A (FPA) were of C-reactive protein (CRP) [12] and interleukin-6 (IL-6) 112 measured both in patients with unstable angina (UA) and [7] have been found. In addition, interleukin-8 (IL-8) has acute myocardial infarction (AMI) [2, 3, 5, 6 ]. Moreover, a been suggested to be a sensitive marker of unstable coronary artery disease [13] .
Both IL-6 and IL-8 are multifunctional cytokines with obtained from all patients. The investigation conformed proinflammatory as well as procoagulant properties. Thus, with the principles outlined in the Declaration of Helsinki. in chimpanzees, the protective effect of anti-IL-6 antibodies in endotoxin-induced coagulation has been demon-2.2. Blood sampling and assays strated [14] . Moreover, IL-8 has been suggested as a key participant in the cross-talk between the coagulation and On admission, before any medication was administered, cytokine cascades [15] . By linking the inflammatory and venous blood samples were collected for CK-MB, TAT, hemostatic systems, IL-6 and IL-8 may play a pivotal role F , FPA, IL-6 and IL-8 measurements. In order to avoid 112 in the pathophysiology of acute coronary syndromes [7, 8] . puncture artifacts, blood was collected by atraumatic The aim of this study was to investigate the relationship venepuncture into tubes containing either trisodium citrate between coagulation and inflammation in the acute phase dihydrate (3.2%) or an anticoagulant mixture from Consecutive patients with characteristic chest pain withThe Mann-Whitney U test was used to evaluate differin the last 12 h before presentation at the emergency room ences between SA, UA and AMI groups. Receiver operwere eligible for the study. Unstable angina was defined by ating characteristic (ROC) curves were fitted from the the presence of at least one episode of ischemic pain of continuously distributed data for IL-6 and FPA with less than 30 min duration, accompanied by diagnostic maximum likelihood estimation, using the computer pro-ST-segment shift or T-wave changes, but without engram CLABROC (by C.E. Metz). The areas under the zymatic evidence of acute myocardial infarction (CK-MB fitted ROC curves were calculated, to estimate the overall levels less than twice the upper limit of normal or 8 U / l). discriminative capacity of the variables. To examine the We aimed to include the patients with ''severely'' unstable discriminative capacity of IL-6, FPA and the combination angina (Braunwald class IIIB), with ST-segment or Tof IL-6 and FPA, logistic regression was used. Disease was wave changes on the electrocardiogram that reacted to defined as the presence of either UA or AMI. Three administration of sublingual nitrates or calcium antagomodels were estimated predicting the probability of disnists. Acute myocardial infarction was defined by a ease, one for IL-6, one for FPA, and one for the combinacombination of ischemic chest pain lasting for more than tion of IL-6 and FPA: P(dis)5b ?IL-61b ?FPA1constant. 1 2 30 min, characteristic ECG changes and a typical rise and The log-likelihood of the models was compared using a fall of CK-MB levels with a peak of more than twice the chi-square test. A ROC curve for the combination of IL-6 upper limit of normal. Exclusion criteria were heparin and FPA was calculated using the predicted values of the administration or fibrinolytic therapy before blood samlogistic regression model. The area under the curve (AUC) pling, known or suspected thrombotic disease, major of the three ROC curves were compared using the method surgery in the past three months, evidence of acute or described by Hanley and McNeil [16] . This method chronic infectious disease or signs of an inflammatory reduces the standard error of differences in area, correcting disorder, oral anticoagulants or anti-inflammatory medicafor the correlation of test results. A probability of p,0.05 tion, with the exception of aspirin. Patients with chronic was considered to be statistically significant. stable angina from the outpatient clinic, characterized by exercise-induced ischemic chest pain and coronary artery disease documented by coronary angiography, without 3. Results changes in symptoms within the previous or following three months, served as controls. The study was approved 3.1. Patients by the institutional review board of the Academic Medical Center and, before participation, informed consent was Procoagulant and proinflammatory activity was mea- with acute ischemic episodes (UA and AMI) from control patients (SA). In contrast, as can be seen in the ROC curves of Fig. 3a , both IL-6 and FPA had equal discriminative capacity. The logistic regression model for the combination of IL-6 and FPA resulted in b 50.68, b 50.034, and a 1 2 constant of 21.31 (22 log-likelihood5148.1). The combined model differed significantly from the two models of the independent tests (IL-6, p,0.0001; FPA, p50.019). In Fig. 3b , the ROC curves for IL-6, FPA and the combination of IL-6 and FPA, calculated according to the logistic regression model, are depicted. The areas under the ROC curves for IL-6 and FPA were 0.79 and 0.75, respectively. For the combination of IL-6 and FPA, the AUC was 0.82. The areas under the three ROC curves were not statistically different, although a trend towards a larger area for the combination of the two markers was seen (IL-6 vs. combination, p50.10; FPA vs. combination, Fig. 2 . Plasma IL-6 levels on admission in patients with unstable angina p50.13). In Fig. 4 , the independent predictive value of (UA), acute myocardial infarction (AMI), compared with stable angina (SA) IL-6 and FPA is visualized by the presence of two with elevated levels of FPA (290 min) and patients with elevated IL-6 levels (300 min) ( p50.34).
Discussion
Both the hemostatic and inflammatory system appear to be involved in the acute phase of ischemic coronary syndromes. The individual contributions and interrelationships between hemostatic changes and inflammatory components in the pathophysiology of acute coronary syndromes, however, are at present unknown. In this study, we investigated the possible relationship between the proinflammatory cytokines (IL-6 and IL-8) and coagulation system activity (TAT, F , FPA) in patients with unstable 112 angina and acute myocardial infarction, compared with a control population consisting of patients with stable angina. To this end, we obtained carefully timed blood samples within 12 h after the onset of symptoms. In addition, patients with UA had diagnostic ST-segment or T-wave changes on admission, as a sign of ongoing instability. We demonstrated a significant difference in levels of FPA and IL-6 in patients with UA and AMI compared to patients with SA, and we showed with ROC analysis that FPA and IL-6 had similar discriminatory capacities for distinguishing stable (SA) from unstable (UA1AMI) patients. However, FPA and IL-6 did not show simultaneous elevation, but were elevated in different patients. TAT, F and IL-8 were not different 112 between the three groups.
Of the coagulation markers measured in this study, only FPA levels were significantly different between the three groups, with median values of 6.2 mg / l in patients with UA and 10.9 mg / l in patients suffering from an AMI, compared to 3.8 mg / l in patients with SA. The ability of FPA to discriminate between patients with stable and unstable angina has been investigated previously. Whereas some investigators reported a significant difference in FPA levels between stable and unstable disease [5, 6] , others could not confirm these findings [17] .
We could not demonstrate a significant difference in plasma levels of TAT complexes and F between SA, 112 UA and AMI. These results confirm the results of an earlier study by Jude et al. [18] , who also failed to demonstrate significant differences in F values between patients with UA and myocardial infarction. In our study, patients were eligible if they presented within 12 h after the onset of symptoms. In contrast, Merlini et al. [2] subpopulations of patients. Thus, patients with elevated included patients within 6 h after the onset of symptoms. plasma levels of FPA and normal IL-6 levels, and patients
The shorter interval between the onset of chest pain and with increased IL-6 concentrations and normal FPA values hospital admission may account for the finding of sigwere observed. The mean time from onset of symptoms nificantly elevated levels of F by these authors, com-112 until hospital admission was not different between patients pared to our study, although the mean interval between the onset of symptoms and blood sampling was less than 6 h undetectable, whereas IL-6 levels were still elevated. The (286 min) in our study as well. Discrepant values of FPA, time from onset of symptoms until hospital admission, F and TAT have been observed in earlier studies in however, was not different between patients with elevated 112 patients with cardiovascular disease. In contrast with the FPA levels and patients with elevated IL-6 levels and, original concept of the ''pre-thrombotic state'', which therefore, cannot explain these findings. In addition, consuggested that upstream markers such as F or TAT sidering the rapid clearance of FPA from the plasma, 112 would be elevated at an earlier stage than downstream increased FPA levels on admission may be the result of an markers such as FPA in patients at risk for thrombosis, ongoing activation of the hemostatic system and repeated more recent studies indicate that FPA is a marker that is ischemic episodes. Low IL-6 levels in these patients may elevated at least as early as the upstream activation indices.
indicate that those ischemic episodes did not induce a In addition to hemostatic parameters, we measured the measurable inflammatory response. One may speculate that extent of simultaneous inflammatory activity in an attempt episodes of unstable coronary artery disease are initiated to associate inflammation and coagulation activation in either by activation of the coagulation system or by acute coronary syndromes, conditions which have been inflammatory activity. However, a dissociation in time shown to be closely linked in human and animal models of between cytokine release and coagulation activation, or inflammation [19] [20] [21] . IL-6 levels were significantly highindividual differences in IL-6 responsiveness, cannot be er in patients with the acute phase of coronary artery excluded. disease than in patients with SA. This is in accordance Interestingly, ROC analysis showed that the inflammawith a study by Biasucci et al. [7] , who demonstrated tory marker IL-6 and the hemostatic marker FPA had elevated levels of IL-6 in a substantial proportion of equivalent discriminative power for the detection of ispatients with UA. In contrast to the report by Kanda et al. chemic coronary syndromes. In addition, in a logistic [13] , in our study, IL-8 levels were not significantly regression model, it was demonstrated that IL-6 and FPA different between stable and unstable coronary artery had independent predictive value. Moreover, a slightly disease. The lack of a difference in plasma levels of IL-8 higher diagnostic efficiency was achieved by combining may be due to binding of IL-8 to the chemokine receptor IL-6 and FPA levels. on the erythrocyte, as we have recently shown in patients
In conclusion, our study shows that plasma levels of with AMI [22] . Unfortunately, measuring erythrocyte-TAT, F and IL-8 are not different between patients with 112 bound IL-8 was not possible in the present study. stable and patients with unstable coronary artery disease. Significant differences in FPA and IL-6 levels between
In contrast, IL-6 and FPA levels are significantly higher in UA and AMI patients were found. The pathogeneses of patients with UA and AMI, than in patients with SA. In UA and AMI are thought to be similar, with the rupture of addition, within a population of patients with unstable an unstable plaque and subsequent thrombus formation, coronary artery disease, hemostatic and inflammatory and the two conditions may represent different ends of the markers can be elevated independently. spectrum. However, the severity of atherosclerosis or plaque burden, area at risk or ischemic burden and size of the thrombus and, possibly, the subsequent elevations of
